CMS issues CY 2027 Physician Fee Schedule final rule (CMS-1848-F): conversion factors fall, same-day E/M and 0-day global payment cut, new 340B Part D claims repository duty
Published November 15, 2026 · Coverage November 8–14, 2026, Pacific · High priority
CMS finalized the calendar year (CY) 2027 Physician Fee Schedule (PFS) rule, CMS-1848-F, published November 9, 2026 and effective January 1, 2027. It lowers both conversion factors, cuts payment when an office or outpatient evaluation and management (E/M) visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it), and requires 340B covered entities to submit claim data to a CMS repository for units of covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, for dates of service from January 1, 2027, with the first quarterly submission due September 30, 2027.

Current status
On November 15, 2026, the Federal Register record for document 2026-22743 still gave an effective date of January 1, 2027 and listed no corrections, and the CMS fact sheet was still posted. No correction to the rule appeared among CMS documents published November 8 to 14, 2026.
Who this affects
Physicians and practitioners billed under the PFS, Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs), independent labs paid under the Clinical Laboratory Fee Schedule (CLFS), 340B covered entities that dispense Part D drugs (including through contract pharmacies), Shared Savings Program accountable care organizations (ACOs).
Why it matters
Inference: professional-fee revenue projections for 2027 need the lower conversion factors; charge masters and coding edits need the B1/B2 modifiers in place of G2211; same-day E/M plus 0-day global billing by the same physician or a physician in the same practice (the condition in the proposal) will pay at 80% for the lesser service; 340B programs need a process and data feed for Part D claims for drugs dispensed by the entity or its contract pharmacies for which a manufacturer provides a 340B discount, starting with January 1, 2027 dates of service; remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) programs that use contracted staff have until January 1, 2029 before the employed-clinical-staff requirement applies.
Required actions
- Apply CY 2027 PFS payment and coding policies to services on or after 2027-01-01 (rule effective 2027-01-01), except where the rule sets a later start, such as the employed-clinical-staff requirement for remote monitoring services, delayed to January 1, 2029.
- Providers and suppliers that are 340B covered entities: submit the required claim data for covered Part D drugs billed to Medicare Part D and dispensed by the entity or its contractors under a 340B discount to the Medicare Part D Claims Data 340B Repository, for claims with dates of service on or after 2027-01-01; first quarterly submission for 2027-01-01 to 2027-03-31 dates of service due 2027-09-30.
Recommended action
- Model 2027 professional revenue at the final conversion factors.
- Update E/M modifier logic (B1, B2) and same-day 0-day global edits before January claims.
- Assign a 340B program owner to scope Part D repository data elements against the full rule text and contract-pharmacy data access.
- ACOs applying for 2027-01-01: decide any track change before the Phase 2 window closes 2026-11-17 at noon ET.
Implementation playbook
- Load the CY 2027 conversion factors ($32.95 for qualifying alternative payment model (APM) participants, $32.63 for others) into the 2027 professional-fee budget and contract models. Owner: Finance and Medical Group Operations. Due: 2026-12-15.
- Update charge capture and claim edits for the reduced payment when an office or outpatient E/M visit is furnished on the same day as a 0-day global procedure by the same physician or a physician in the same practice (the condition as CMS proposed it; confirm it in the published rule), and for modifier B1 in place of G2211 (B2 for Shared Savings Program ACOs and Long-term Enhanced ACO Design (LEAD) Model ACOs). Owner: Revenue Cycle and Coding. Due: 2026-12-31, ahead of the January 1, 2027 effective date.
- 340B covered entities: name an owner for submitting claim data to the 340B Repository for covered Part D drugs dispensed by the entity or its contractors for which a manufacturer provides a 340B discount, confirm the data feed for dates of service from January 1, 2027, and calendar the first quarterly submission. Owner: Pharmacy 340B program and Compliance. Due: process ready 2027-01-01; first submission 2027-09-30 (the fact sheet's date).
- Shared Savings Program applicants for a January 1, 2027 start: decide on any track change. Owner: ACO leadership. Due: 2026-11-17, noon Eastern (the fact sheet's window).
- Read the published rule (91 FR 70992) for provisions the fact sheets do not cover, and correct this entry if the rule text differs. Owner: Compliance. Due: 2026-12-01.
Scope and timing
- Authority status
- Final
- Responsible owner
- Revenue Cycle (professional billing); Pharmacy/340B program for the repository duty
- Publication date
- 2026-11-09 (Federal Register, 91 FR 70992). CMS fact sheet and press release dated 2026-11-04; placed on public inspection 2026-11-04
- Effective date
- 2027-01-01
- Compliance date
- 2027-09-30: first mandatory quarterly submission to the 340B Repository, covering dates of service in the first quarter of 2027
- Implementation date
- Requirement for employed clinical staff in remote monitoring services begins with CY 2029
- Other dates
- Shared Savings Program applicants for a January 1, 2027 start may change track during the Phase 2 window, 2026-11-12 to 2026-11-17 at noon Eastern
Not established
The 340B repository submission specifications were not checked.
Earlier article: November 8, 2026 edition →
Sources
Complete edition and supplemental material
This article in the complete report →
Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.
Read the entire Medicare & Medicaid Sweep report →